Mutations in one or more of the genes that encode amyloid precursor protein (APP), presenilin 1 (PS1), or presenilin 2 (PS2) represent genetic risk factors for AD (Gaiteri et al., 2016) and are typically associated with early-onset AD, but account for less than half of all cases. This evidence concerns the gene APP and Alzheimer disease.